Jazz Pharmaceuticals (JAZZ) Tops Q4 Views; Guides FY11 Above Street
Tweet Send to a Friend
Jazz Pharmaceuticals (NASDAQ: JAZZ) reported Q4 EPS of $0.63, $0.03 better than ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
